I work as an assistant professor at the Alzheimer Centre Limburg at Maastricht University and am affiliated to the Karolinska Institutet. I'm part of the International Pharmaco-Economic collaboration on Alzheimer’s Disease (www.ipecad.org). My background is in epidemiology and cost-effectiveness analysis in Alzheimer’s disease (AD). I perform research in the area of (early) cost-effectiveness of diagnosis and treatment of AD, and natural AD disease progression. My work has been funded by national and international funding schemes (among which ZonMw, H2020, JPND and IMI). On an occasional basis I provide advisory for pharmaceutical organizations.